Nabriva Therapeutics plc

Historical 13F Holders

Symbol
NBRV
CUSIP
G63637105
All holders as of
Q2 2022
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q2 1 3.00 k $1.00 k
2022 Q1 1 5.00 k $2.00 k
2021 Q4 1 5.00 k $3.00 k
2021 Q3 1 5.00 k $6.00 k
2021 Q2 2 5.00 k $7.00 k
2021 Q1 2 5.00 k $8.00 k
2020 Q4 3 196 k $474 k
2020 Q3 55 36.2 M $16.4 M
2020 Q2 59 37.5 M $21.7 M
2020 Q1 58 23.3 M $14.3 M
2019 Q4 55 28.3 M $37.3 M
2019 Q3 50 23.3 M $46.6 M
2019 Q2 50 29.5 M $71.4 M
2019 Q1 44 29.1 M $71.1 M
2018 Q4 51 32.3 M $47.1 M
2018 Q3 48 31.9 M $85.9 M
2018 Q2 46 21.1 M $73.3 M
2018 Q1 49 25.3 M $127 M
2017 Q4 45 22.5 M $135 M
2017 Q3 42 21.5 M $176 M
2017 Q2 20 12.6 M $134 M